Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.83 AUD | 0.00% | 0.00% | -2.41% |
02-27 | Probiotec Limited Declares Interim Dividend, Payable on 15 March 2024 | CI |
02-27 | Probiotec Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Strengths
- Over the last twelve months, the sales forecast has been frequently revised upwards.
Ratings chart - Surperformance
Sector: Pharmaceuticals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-2.41% | 152M | - | ||
+26.08% | 662B | C+ | ||
+21.85% | 546B | B | ||
-4.77% | 359B | C+ | ||
+16.97% | 323B | B- | ||
+5.69% | 290B | C+ | ||
+13.68% | 234B | B+ | ||
+3.65% | 198B | B- | ||
-11.12% | 194B | A+ | ||
+8.08% | 167B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- PBP Stock
- Ratings Probiotec Limited